Biosurgery Market Size 2022 to 2030 - Quantitative Research by QYResearch Medical

The global biosurgery market size was USD 11.45 billion in 2020 and is expected to register a revenue CAGR of 5.4% during the forecast period.

Steady global biosurgery market revenue growth can be attributed to rapidly increasing use of biosurgery products in the healthcare sector for different surgical procedures. Increasing number of orthopedic procedures due to increasing geriatric population and obesity and rising awareness regarding technologically advanced procedures are other factors driving market revenue growth.

Biosurgery market is one of the fastest growing markets in the medical field. Biosurgery comprises biological surgical elements, bone-graft substitutes, soft tissue management, hemostatic agents, and others. These biosurgery products help surgeons and medical professionals in treating injuries effectively and efficiently.

Inquiry Before Buying@

Biosurgery is also used in treatment of chronically infected wounds that are resistant to antibiotics. Biosurgery is extensively applied in the treatment of disorders such as neurological, cardiovascular, and other chronic disorders. Biosurgery primarily helps in efficient recuperation of wounds.

Furthermore, biosurgery therapy is helpful for patients suffering from diabetes. Increasing incidence of diabetes and spinal cord injuries is expected to support biosurgery market revenue growth during the forecast period. Increasing demand for minimally invasive surgical procedures and rapidly increasing ageing population with chronic diseases and disorders are other key factors driving market growth. A large number of individuals suffering from obesity are prone to various health-related consequences such as orthopedic and neurological disorders, which would further increase demand for surgeries to treat such diseases.

Market Dynamics:

Driver: Rising Demand for Biosurgery for Prevention of Blood Loss During Surgeries

Biosurgery market is expected to register rapid growth owing to increasing number of accidents and surgeries that result in major blood loss are driving need for biosurgery. Entry of new players in the market and implementation of modern marketing endorsements are some factors attributed to high demand for biosurgery products. Improved reimbursement policies and high demand for biosurgery products will continue to drive growth of the biosurgery market. Technological advancements in research and development of various products that are highly efficient, as well as increasing number of surgeries due to presence of a large population suffering from various types of disorders is driving market revenue growth. Increasing healthcare expenditure is also expected to boost global biosurgery market revenue growth.

Restraint: High Cost of Biosurgery Products and Emergence of Advanced Surgical Procedures

High cost of biosurgery products and advanced surgical procedures in the healthcare sector are expected to limit market revenue growth to some extent. Besides, high manufacturing cost, stringent rules and regulations governing the usage of biosurgery products, and complicated amalgamation processes are expected to hamper market growth in the near future. Furthermore, limitation in the number of clinical trials and lack of awareness regarding biosurgery can hamper market revenue growth.

Product Type Outlook:

Based on product type, the global biosurgery market has been segmented into bone-graft substitutes, soft-tissue attachments, hemostatic agents, surgical sealants & adhesives, adhesion barriers, and staple-line reinforcement agents. Bone-graft substitute products are used in orthopedic surgeries and dental surgeries. These are more beneficial than other biosurgery products and hence demand is expected to continue to increase in future, and contribute to market revenue growth. Increasing incidence of sports-related injuries and back pain has raised demand for surgical sealants & adhesives. Soft tissue attachments have a wide range of applications in different types of surgeries. Increasing prevalence of lifestyle diseases and rising number of surgeries that are being performed in the healthcare sector have surged demand for biosurgery products, which is driving market growth.

Related Reports:

End-use Outlook:

Based on end-use, the global biosurgery market has been segmented into hospitals, clinics, ambulatory surgical centers, and others. Hospitals segment contributed largest revenue share in 2020 because of increasing number of general and gynecological surgeries that are being performed in hospitals, compared to other end-use segments. Increasing number of multi-specialty hospitals and emergence of modern biosurgery treatment procedures have also boosted the biosurgery market. Ambulatory surgical centers segment, on the other hand, is expected grow at significant revenue CAGR over the forecast period, owing to increasing incidence of road accidents & sports injuries and availability of same-day surgical care in ambulatory surgical centers.

Application Outlook:

Based on application, the global biosurgery market has been segmented orthopedic surgery, general surgery, neurological surgery, cardiovascular surgery, gynecological surgery, reconstructive surgery. Orthopedic surgery segment accounted for largest revenue share in 2020. Growth of this segment is due to increasing number of accidents and sports injuries. Besides, increasing geriatric population and rising prevalence of knee injuries would lead to surging cases of orthopedic disorders that is set to contribute to market growth. Increasing number of orthopedic surgeries worldwide and rapid inclination of people towards biosurgery is also driving market growth.

Reconstructive surgery segment revenue is expected grow at a significant revenue CAGR over the forecast period. Revenue growth of this segment is driven by increasing number of minimally invasive cosmetic surgeries, increasing prevalence of burn wounds, large number of individuals suffering from skin disorders, and increasing prevalence of breast cancer leading to need for various types of surgery.

Regional Outlook:

Biosurgery market in North America accounted for largest revenue share in 2020, attributed to key drivers such as increasing obesity, which is further increasing incidence of orthopedic surgeries, need for advanced surgical procedures, increasing funds in the healthcare sector, and rising awareness regarding the benefits. Use of advanced technologies and procedures and presence of a well-developed healthcare infrastructure are also factors driving growth of the market in the region.

Biosurgery market in Asia Pacific is expected to register fastest revenue CAGR over the forecast period, owing to presence of a large number of major players and favorable government initiatives to promote provision of advancement of treatment. Asia Pacific has a large number of patients with various disorders and injuries, which in turn, is resulting in high demand for reconstructive surgeries. 

Competitive Landscape: 

The global biosurgery market is moderately fragmented with a number of key players operating on global and regional levels. Key players are engaged in product development and strategic alliances to expand respective product portfolios and gain a robust footing in the global market.

Some players in the market include Baxter International Inc., B. Braun Melsungen AG Becton, Dickson and Company, CSL Limited, Cryolife Inc., Hemostasis LLC, Integra Lifesciences Holding Corporation, Johnson & Johnson, Kuros Biosciences AG, Medtronic PLC, Smith & Nephew Plc., and Zimmer Biomet.

Some key developments in the market:

  • In February 2020, Baxter announced 510 (k) clearance from US FDA for Peri-strips Dry with Veritas Collagen Matrix product with Secure Grip. This product is a staple-line reinforcement agent and is indicated for mitigating bleeding during bariatric surgeries and other surgical procedures.
  • In October 2020, Orthofix Medical Inc., which is a global medical device company, announced the launch of O-GENESIS Graft Delivery System and AlloQuent Structural Allograft Q-Pack, which is a ready-to-use cervical and lumbar spacers for allograft procedures.

Segments Covered in the Report:

This report offers historical data and forecasts revenue growth at a global, regional, and country level, and provides analysis of market trends for segments and sub-segments from 2018 to 2030. For this study, Reports and Data has segmented biosurgery market based on product type, end-use, application, and region:  

Inquiry Before Buying@

Biosurgery Market Report Scope

Segments covered By Product Type Outlook, End-use Outlook, Application Outlook, Regional Outlook

By Product Type Outlook            

  • Bone-graft Substitutes
  • Cell-based Matrices
  • Bone Morphogenetic
  • Demineralized Bone Matrix
  • Synthetic Graft Extender
  • Soft-tissue Attachments
  • Biological Mesh/Patch
  • Synthetic Mesh/Patch
  • Hemostatic Agents
  • Thrombin-Based Hemostatic Agent
  • Oxidized Regenerated Cellulose-Based Hemostatic Agents
  • Combined Hemostatic Agents
  • Adhesion Barriers
  • Synthetic Adhesion Barriers
  • Natural Adhesion Barriers
  • Surgical Sealants & Adhesives
  • Staple Line Reinforcement Agents

By End-use Outlook       

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

By Application Outlook

  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Gynecological Surgery
  • Reconstructive Surgery
  • Others

Regional scope

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Buy quantitative research Report at discounted price - USD 1500

You can place an order or ask any questions, please feel free to contact | +1 9197 992 333



About Us

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.

For Latest Update Follow Us:



Back to news